2019 Annual Meeting | C225 - Actualización científica II (Scientific Update II)
Program Materials Program Evaluations
01:00 PM - 01:30 PM EDT | Speaker |
Enfermedades neuromusculares
Alejandro Tobon, MD, FAAN |
01:30 PM - 02:00 PM EDT | Speaker |
Esclerosis Múltiple
Daniel Ontaneda, MD, PhD, FAAN |
02:00 PM - 02:30 PM EDT | Speaker |
Epilepsia
Luis C. Mayor-Romero, MD |
02:30 PM - 03:00 PM EDT | Q&A |
Preguntas y discusión
|
Alejandro Tobon, MD, FAAN | Dr. Tobon has nothing to disclose. |
Luis C. Mayor-Romero, MD | Dr. Mayor-Romero has nothing to disclose. |
Daniel Ontaneda, MD, PhD, FAAN | Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech. |